CSTL CASTLE BIOSCIENCES INC
2026Q1 · CUSIP 14843C105 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
186
Δ holders QoQ
-8
Breadth percentile
Top 83%
Whale holders
100
Δ whales
-3
Inst. holding value
$676M
New positions
30
Closed positions
38
Price momentum (1Q)
-42.2%
Put / Call
1/3
Breadth history (34 quarters)
Past Lit Events & Aftermath 6 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 16% | -7.7% | -41.0% |
| 2024Q3 | Top 12% | -7.7% | -43.0% |
| 2022Q3 | Top 13% | +19.4% | +13.0% |
| 2020Q3 | Top 14% | +75.0% | +17.0% |
| 2020Q2 | Top 8% | +15.3% | +106.5% |
| 2020Q1 | Top 3% | +22.5% | +41.3% |
Options Sentiment
Put holders
1
QoQ: +1
Call holders
3
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.42
EPS YoY
—
Revenue (TTM)
$0.3B
Revenue YoY
-2.1%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)